[Chemoradiotherapy of carcinomas of the upper aerodigestive tract] (Q77919346)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922773%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

review article

1 reference

title

[Chemoradiotherapy of carcinomas of the upper aerodigestive tract] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922773%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

J Bourhis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922773%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

G Calais

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922773%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

F Eschwège

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922773%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922773%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922773%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922773%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

679-688

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922773%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922773%20AND%20SRC:MED&resulttype=core&format=json

Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Combined radiation and drugs: the effect of intra-arterial chemotherapy followed by radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Treatment of advanced head and neck cancer by means of radiation therapy plus chemotherapy — a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Status of accelerated fractionation radiotherapy in head and neck squamous cell carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Induction chemotherapy in advanced head and neck cancer. Preliminary results of a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progr

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Induction chemotherapy in advanced head and neck tumors: results of two randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Cancer in the European community and its member states

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Randomized study of zorubicin versus zorubicin-cisplatin in undifferentiated carcinoma of the nasopharynx (UCNT)

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Methotrexate and radiation therapy in the treatment of advanced head and neck tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Randomized comparison of two chemotherapy, radiotherapy schemes for stage III and IV unresectable squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Treatment of advanced head and neck cancer: Multiple daily dose fractionated radiation therapy and sequential multimodal treatment approach

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Combined bleomycin treatment and radiation therapy in squamous cell carcinoma of the head and neck region

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

A randomized comparison of radiotherapy with a radiotherapy--chemotherapy combination in stage IV carcinoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Meta-analysis of chemotherapy in head and neck cancer: individual patient data vs literature data

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Intra-arterial methotrexate chemotherapy and telecobalt therapy in cancer of the oral cavity and oropharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Randomized trial of induction chemotherapy in larynx carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Combined bleomycin and radiotherapy in oral cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Hydroxyurea and radiotherapy in head and neck cancer. Results of a prospective controlled study in 126 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Sequential chemotherapy and radiotherapy in advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Bleomycin and radiation therapy in squamous cell carcinoma of the upper aero-digestive tract: a phase III clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Sequential chemotherapy and radiation therapy of buccal mucosa carcinoma in South India. Methods and preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

Simultaneous Chemoradiation in the Treatment of Advanced Head and Neck Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2899%2980008-0

7 January 2021

10.1016/S1278-3218(99)80008-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922773%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference